Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates

Over the last four quarters, the company has surpassed consensus EPS estimates four times. Amgen (AMGN) came out with quarterly earnings of $6.02 per share, beating the Zacks Consensus Estimate of$ 5.26 per share. This compares to earnings of $4.97 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of +14.45%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of$ 4.16 per share when it ...